查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968677

CT及MRI造影劑市場分析及預測（至2035年）：類型、產品類型、應用、技術、最終用戶、劑型、材質類型、功能、組件、設備

CT And MRI Contrast Agents Market Analysis and Forecast to 2035: Type, Product, Application, Technology, End User, Form, Material Type, Functionality, Component, Equipment
出版日期: | 出版商: Global Insight Services | 英文 482 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

CT和MRI造影劑市場預計將從2024年的83.9億美元成長到2034年的158.5億美元，複合年成長率約為6.6%。 CT和MRI造影劑市場涵蓋用於增強電腦斷層掃描（CT）和磁振造影（MRI）中體內結構清晰度和可見度的物質。這些造影劑在診斷影像中至關重要，能夠提高組織和血管結構的區分度。推動市場成長的因素包括慢性疾病的增加、影像技術的進步以及對早期準確診斷日益成長的需求。造影劑成分和給藥方法的創新以及造影核准對於塑造市場動態和擴張至關重要。

受影像技術進步和診斷程序增加的推動，CT和MRI造影劑市場預計將迎來顯著成長。就產品細分而言，碘基造影劑因其在CT影像中的廣泛應用而佔據主導地位。钆基造影劑因其在MRI檢查中的有效性而佔據第二大市場。就應用領域而言，神經影像學引領市場，這主要得益於神經系統疾病的日益增加。心血管影像學緊隨其後，這主要歸因於心血管疾病發生率的上升以及對精準診斷的需求。醫院是主要的終端用戶，這得益於其全面的診斷能力和先進成像設備的普及。診斷影像中心是第二大收入來源，它們提供快速出具結果的專業影像服務。微氣泡造影技術的進步正在提高成像的準確性並拓展應用範圍，從而帶來新的機會。對病人安全和法規遵從性的關注仍然至關重要，這影響著產品開發和市場策略。

市場區隔
種類 碘基造影劑、钆基造影劑、微氣泡造影劑
產品 口服造影、靜脈注射造影、直腸造影
目的 心臟病學、神經病學、腫瘤學、消化病學、腎臟病學
科技 電腦斷層掃描（CT）、磁振造影（MRI）
最終用戶 醫院、影像診斷中心及門診手術中心
形式 液體、粉末
材料類型 有機物、無機物
功能 用於診斷和治療
成分 活性藥物成分和添加劑
裝置 CT掃描儀， 核磁共振造影系統

市場概況：

CT和MRI造影劑市場以產品種類繁多和價格競爭激烈為特徵。現有企業持續保持主導地位，而新參與企業不斷推出創新產品，活性化市場動態。價格戰持續進行，各公司專注於以價值為導向的提案來擴大市場佔有率。先進的造影劑不斷湧現，有望提高診斷準確性和病人安全性。這些發展對於維持產業發展動能和滿足醫療專業人員不斷變化的需求至關重要。市場競爭異常激烈，主要企業透過策略聯盟和收購爭奪市場領導地位。區域法規結構對市場動態重大影響，嚴格的合規要求塑造了產品開發和核准流程。北美市場依然強勁，這得益於技術進步和有利的報銷政策。同時，由於醫療保健投資的增加，亞太地區正在經歷快速成長。總體而言，在對精準診斷影像需求不斷成長和造影劑技術創新的推動下，市場呈現擴張跡象。

主要趨勢和促進因素：

由於影像技術的進步和慢性病發病率的上升，CT和MRI造影劑市場正經歷強勁成長。主要趨勢包括新型造影劑的研發，這些造影劑能夠提高影像品質和診斷準確性。這些創新使得疾病的檢測和表徵更加精準，有助於改善患者的治療效果。老年人口的成長（他們罹患慢性病的風險更高）進一步推動了對先進影像解決方案的需求。此外，向非侵入性診斷技術的轉變也促進了造影劑的應用。醫療機構越來越重視病人的安全和舒適度，優先考慮微創成像方式。監管部門的核准和有利的報銷政策也在市場擴張中發揮關鍵作用。新興地區醫療基礎設施的快速發展帶來了新的機會。專注於提供經濟高效造影劑解決方案的公司有望佔據顯著的市場佔有率。此外，策略聯盟和夥伴關係正在促進創新產品的開發，並推動市場成長。隨著全球醫療系統努力提升診斷能力，CT和MRI造影劑市場預計將持續擴張。

限制與挑戰：

CT和MRI造影劑市場面臨許多重大限制和挑戰。主要阻礙因素是嚴格的監管要求，這延長了核准流程並增加了生產成本。此外，造影劑的高成本限制了其可近性，尤其是在醫療預算有限的新興市場。潛在的副作用和過敏反應等安全隱患也使市場格局更加複雜，需要嚴格的測試和監測。此外，超音波和先進的非造影MRI技術等無需造影劑的替代成像方式的日益普及也對市場構成挑戰。同時，對個人化醫療的日益重視推動了對患者特異性造影劑的需求，增加了生產的複雜性和研發成本。這些因素共同構成了重大障礙，影響著市場的成長軌跡和可近性。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 碘造影劑
    • 钆基造影劑
    • 微氣泡造影劑
  • 市場規模及預測：依產品分類
    • 口服造影
    • 靜脈造影顯影劑
    • 直腸造影劑
  • 市場規模及預測：依應用領域分類
    • 心臟病學
    • 神經病學
    • 腫瘤學
    • 胃腸內視鏡檢查
    • 腎臟病學
  • 市場規模及預測：依技術分類
    • 電腦斷層掃描（CT）
    • 磁振造影（MRI）
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷影像中心
    • 門診手術中心
  • 市場規模及預測：依類型
    • 液體
    • 粉末
  • 市場規模及預測：依材料類型分類
    • 有機的
    • 無機物
  • 市場規模及預測：依功能分類
    • 診斷
    • 治療
  • 市場規模及預測：依組件分類
    • 原料藥
    • 添加劑
  • 市場規模及預測：依設備分類
    • CT掃描儀
    • 核磁共振造影系統

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Bracco Imaging
  • Guerbet
  • Lantheus Medical Imaging
  • Daiichi Sankyo
  • JB Chemicals and Pharmaceuticals
  • Unijules Life Sciences
  • Taejoon Pharm
  • Jodas Expoim
  • Sanochemia Pharmazeutika
  • Spago Nanomedical
  • CMR Naviscan
  • YMBioSciences
  • iMax Diagnostic Imaging
  • Beekley Medical
  • Trivitron Healthcare
  • Magnus Life
  • NantPharma
  • Aspen Pharmacare
  • Ekomed

第9章：關於我們

簡介目錄
Product Code: GIS33084

CT And MRI Contrast Agents Market is anticipated to expand from $8.39 billion in 2024 to $15.85 billion by 2034, growing at a CAGR of approximately 6.6%. The CT and MRI Contrast Agents Market encompasses substances used to enhance the clarity and visibility of internal body structures in computed tomography (CT) and magnetic resonance imaging (MRI) scans. These agents, crucial in diagnostic imaging, improve the differentiation of tissues and vascular structures. The market is driven by increasing prevalence of chronic diseases, advancements in imaging technologies, and rising demand for early and accurate diagnosis. Innovations in agent composition and delivery, alongside regulatory approvals, are pivotal in shaping market dynamics and expansion.

The CT and MRI Contrast Agents Market is poised for significant growth, spurred by advancements in imaging technologies and rising diagnostic procedures. In the product segment, iodinated contrast agents are leading, attributed to their widespread use in CT imaging. Gadolinium-based agents are the second highest performers, driven by their efficacy in MRI procedures. Among applications, neurological imaging holds the top position, benefiting from the increasing prevalence of neurological disorders. Cardiovascular imaging follows closely, supported by the rising incidence of cardiovascular diseases and the need for accurate diagnosis. The hospital segment is the primary end-user, given its comprehensive diagnostic capabilities and access to advanced imaging equipment. Diagnostic imaging centers are the second most lucrative, as they offer specialized imaging services with quicker turnaround times. Technological advancements, such as the development of microbubble contrast agents, present new opportunities, enhancing imaging precision and expanding application areas. The focus on patient safety and regulatory compliance remains paramount, influencing product development and market strategies.

Market Segmentation
TypeIodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media
ProductOral Contrast Agents, Intravenous Contrast Agents, Rectal Contrast Agents
ApplicationCardiology, Neurology, Oncology, Gastroenterology, Nephrology
TechnologyComputed Tomography (CT), Magnetic Resonance Imaging (MRI)
End UserHospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers
FormLiquid, Powder
Material TypeOrganic, Inorganic
FunctionalityDiagnostic, Therapeutic
ComponentActive Pharmaceutical Ingredients, Excipients
EquipmentCT Scanners, MRI Machines

Market Snapshot:

The CT and MRI contrast agents market is characterized by a diverse array of products and competitive pricing strategies. Established players continue to dominate, yet new entrants are launching innovative products, intensifying market dynamics. Pricing remains competitive, with companies focusing on value-driven propositions to enhance their market share. The market sees a steady introduction of advanced contrast agents, which promise improved diagnostic accuracy and patient safety. These developments are crucial in maintaining the industry's momentum and addressing the evolving needs of healthcare professionals. Competition is fierce, with major firms vying for market leadership through strategic partnerships and acquisitions. Regulatory frameworks across regions significantly influence market dynamics, with stringent compliance requirements shaping product development and approval processes. The North American market is robust, driven by technological advancements and favorable reimbursement policies. Meanwhile, the Asia-Pacific region is witnessing rapid growth due to increasing healthcare investments. Overall, the market is poised for expansion, fueled by rising demand for precise diagnostic imaging and innovations in contrast agent technologies.

Geographical Overview:

The CT and MRI contrast agents market is witnessing notable growth across diverse regions, each exhibiting unique characteristics. North America remains a dominant force, propelled by advanced healthcare infrastructure and increasing demand for diagnostic imaging. The presence of key players and ongoing research initiatives further bolster the market's expansion. Europe follows as a significant contributor, with rising healthcare expenditures and a growing elderly population driving the demand for contrast agents. Asia Pacific emerges as a promising growth pocket, fueled by rapid urbanization and an expanding middle class seeking improved healthcare services. China and India are at the forefront, with substantial investments in healthcare infrastructure and technology adoption. Latin America and the Middle East & Africa are gaining traction as emerging markets. In Latin America, improving healthcare facilities and a focus on enhancing diagnostic capabilities are key growth drivers. Meanwhile, the Middle East & Africa are witnessing increased investments in healthcare to support economic development and innovation.

Key Trends and Drivers:

The CT and MRI contrast agents market is experiencing robust growth driven by technological advancements in imaging techniques and increasing prevalence of chronic diseases. Key trends include the development of novel contrast agents that enhance image quality and diagnostic accuracy. These innovations are enabling more precise detection and characterization of medical conditions, thereby improving patient outcomes. The growing geriatric population, with its higher susceptibility to chronic diseases, is further fueling demand for advanced imaging solutions. Additionally, the shift towards non-invasive diagnostic procedures is propelling the adoption of contrast agents. Healthcare providers are increasingly prioritizing patient safety and comfort, leading to a preference for imaging modalities that minimize invasiveness. Regulatory approvals and favorable reimbursement policies are also playing a pivotal role in market expansion. Opportunities are emerging in developing regions where healthcare infrastructure is rapidly advancing. Companies focusing on affordable and effective contrast solutions are poised to capture significant market share. Furthermore, strategic collaborations and partnerships are facilitating the development of innovative products, thus driving market growth. As healthcare systems worldwide strive for improved diagnostic capabilities, the CT and MRI contrast agents market is set to witness sustained expansion.

Restraints and Challenges:

The CT and MRI contrast agents market encounters several significant restraints and challenges. A primary restraint is the stringent regulatory requirements, which prolong approval processes and increase costs for manufacturers. Additionally, the high cost of contrast agents limits accessibility, especially in emerging markets with constrained healthcare budgets. Safety concerns regarding potential side effects and allergic reactions further complicate the market landscape, necessitating rigorous testing and monitoring. The market also faces challenges from the increasing adoption of alternative imaging modalities that do not require contrast agents, such as ultrasound or advanced non-contrast MRI techniques. Moreover, the growing emphasis on personalized medicine demands tailored contrast agents, complicating production and increasing research and development expenditures. These factors collectively pose significant hurdles, impacting the market's growth trajectory and accessibility.

Key Players:

Bracco Imaging, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, J.B. Chemicals and Pharmaceuticals, Unijules Life Sciences, Taejoon Pharm, Jodas Expoim, Sanochemia Pharmazeutika, Spago Nanomedical, CMR Naviscan, YMBioSciences, iMax Diagnostic Imaging, Beekley Medical, Trivitron Healthcare, Magnus Life, NantPharma, Aspen Pharmacare, Ekomed

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by End User
  • 2.6 Key Market Highlights by Form
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Component
  • 2.10 Key Market Highlights by Equipment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Iodinated Contrast Media
    • 4.1.2 Gadolinium-based Contrast Media
    • 4.1.3 Microbubble Contrast Media
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Oral Contrast Agents
    • 4.2.2 Intravenous Contrast Agents
    • 4.2.3 Rectal Contrast Agents
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Cardiology
    • 4.3.2 Neurology
    • 4.3.3 Oncology
    • 4.3.4 Gastroenterology
    • 4.3.5 Nephrology
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Computed Tomography (CT)
    • 4.4.2 Magnetic Resonance Imaging (MRI)
  • 4.5 Market Size & Forecast by End User (2020-2035)
    • 4.5.1 Hospitals
    • 4.5.2 Diagnostic Imaging Centers
    • 4.5.3 Ambulatory Surgical Centers
  • 4.6 Market Size & Forecast by Form (2020-2035)
    • 4.6.1 Liquid
    • 4.6.2 Powder
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Organic
    • 4.7.2 Inorganic
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Diagnostic
    • 4.8.2 Therapeutic
  • 4.9 Market Size & Forecast by Component (2020-2035)
    • 4.9.1 Active Pharmaceutical Ingredients
    • 4.9.2 Excipients
  • 4.10 Market Size & Forecast by Equipment (2020-2035)
    • 4.10.1 CT Scanners
    • 4.10.2 MRI Machines

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 Technology
      • 5.2.1.5 End User
      • 5.2.1.6 Form
      • 5.2.1.7 Material Type
      • 5.2.1.8 Functionality
      • 5.2.1.9 Component
      • 5.2.1.10 Equipment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 Technology
      • 5.2.2.5 End User
      • 5.2.2.6 Form
      • 5.2.2.7 Material Type
      • 5.2.2.8 Functionality
      • 5.2.2.9 Component
      • 5.2.2.10 Equipment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 Technology
      • 5.2.3.5 End User
      • 5.2.3.6 Form
      • 5.2.3.7 Material Type
      • 5.2.3.8 Functionality
      • 5.2.3.9 Component
      • 5.2.3.10 Equipment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 Technology
      • 5.3.1.5 End User
      • 5.3.1.6 Form
      • 5.3.1.7 Material Type
      • 5.3.1.8 Functionality
      • 5.3.1.9 Component
      • 5.3.1.10 Equipment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 Technology
      • 5.3.2.5 End User
      • 5.3.2.6 Form
      • 5.3.2.7 Material Type
      • 5.3.2.8 Functionality
      • 5.3.2.9 Component
      • 5.3.2.10 Equipment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 Technology
      • 5.3.3.5 End User
      • 5.3.3.6 Form
      • 5.3.3.7 Material Type
      • 5.3.3.8 Functionality
      • 5.3.3.9 Component
      • 5.3.3.10 Equipment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 Technology
      • 5.4.1.5 End User
      • 5.4.1.6 Form
      • 5.4.1.7 Material Type
      • 5.4.1.8 Functionality
      • 5.4.1.9 Component
      • 5.4.1.10 Equipment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 Technology
      • 5.4.2.5 End User
      • 5.4.2.6 Form
      • 5.4.2.7 Material Type
      • 5.4.2.8 Functionality
      • 5.4.2.9 Component
      • 5.4.2.10 Equipment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 Technology
      • 5.4.3.5 End User
      • 5.4.3.6 Form
      • 5.4.3.7 Material Type
      • 5.4.3.8 Functionality
      • 5.4.3.9 Component
      • 5.4.3.10 Equipment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 Technology
      • 5.4.4.5 End User
      • 5.4.4.6 Form
      • 5.4.4.7 Material Type
      • 5.4.4.8 Functionality
      • 5.4.4.9 Component
      • 5.4.4.10 Equipment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 Technology
      • 5.4.5.5 End User
      • 5.4.5.6 Form
      • 5.4.5.7 Material Type
      • 5.4.5.8 Functionality
      • 5.4.5.9 Component
      • 5.4.5.10 Equipment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 Technology
      • 5.4.6.5 End User
      • 5.4.6.6 Form
      • 5.4.6.7 Material Type
      • 5.4.6.8 Functionality
      • 5.4.6.9 Component
      • 5.4.6.10 Equipment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 Technology
      • 5.4.7.5 End User
      • 5.4.7.6 Form
      • 5.4.7.7 Material Type
      • 5.4.7.8 Functionality
      • 5.4.7.9 Component
      • 5.4.7.10 Equipment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 Technology
      • 5.5.1.5 End User
      • 5.5.1.6 Form
      • 5.5.1.7 Material Type
      • 5.5.1.8 Functionality
      • 5.5.1.9 Component
      • 5.5.1.10 Equipment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 Technology
      • 5.5.2.5 End User
      • 5.5.2.6 Form
      • 5.5.2.7 Material Type
      • 5.5.2.8 Functionality
      • 5.5.2.9 Component
      • 5.5.2.10 Equipment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 Technology
      • 5.5.3.5 End User
      • 5.5.3.6 Form
      • 5.5.3.7 Material Type
      • 5.5.3.8 Functionality
      • 5.5.3.9 Component
      • 5.5.3.10 Equipment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 Technology
      • 5.5.4.5 End User
      • 5.5.4.6 Form
      • 5.5.4.7 Material Type
      • 5.5.4.8 Functionality
      • 5.5.4.9 Component
      • 5.5.4.10 Equipment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 Technology
      • 5.5.5.5 End User
      • 5.5.5.6 Form
      • 5.5.5.7 Material Type
      • 5.5.5.8 Functionality
      • 5.5.5.9 Component
      • 5.5.5.10 Equipment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 Technology
      • 5.5.6.5 End User
      • 5.5.6.6 Form
      • 5.5.6.7 Material Type
      • 5.5.6.8 Functionality
      • 5.5.6.9 Component
      • 5.5.6.10 Equipment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 Technology
      • 5.6.1.5 End User
      • 5.6.1.6 Form
      • 5.6.1.7 Material Type
      • 5.6.1.8 Functionality
      • 5.6.1.9 Component
      • 5.6.1.10 Equipment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 Technology
      • 5.6.2.5 End User
      • 5.6.2.6 Form
      • 5.6.2.7 Material Type
      • 5.6.2.8 Functionality
      • 5.6.2.9 Component
      • 5.6.2.10 Equipment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 Technology
      • 5.6.3.5 End User
      • 5.6.3.6 Form
      • 5.6.3.7 Material Type
      • 5.6.3.8 Functionality
      • 5.6.3.9 Component
      • 5.6.3.10 Equipment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 Technology
      • 5.6.4.5 End User
      • 5.6.4.6 Form
      • 5.6.4.7 Material Type
      • 5.6.4.8 Functionality
      • 5.6.4.9 Component
      • 5.6.4.10 Equipment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 Technology
      • 5.6.5.5 End User
      • 5.6.5.6 Form
      • 5.6.5.7 Material Type
      • 5.6.5.8 Functionality
      • 5.6.5.9 Component
      • 5.6.5.10 Equipment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bracco Imaging
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Guerbet
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Lantheus Medical Imaging
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Daiichi Sankyo
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 J.B. Chemicals and Pharmaceuticals
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Unijules Life Sciences
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Taejoon Pharm
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Jodas Expoim
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Sanochemia Pharmazeutika
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Spago Nanomedical
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 CMR Naviscan
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 YMBioSciences
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 iMax Diagnostic Imaging
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Beekley Medical
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Trivitron Healthcare
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Magnus Life
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 NantPharma
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Aspen Pharmacare
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Ekomed
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us